For children hospitalized with bronchiolitis, intermittent pulse oximetry did not shorten length of hospital stay (LOS), nor did it result in any difference in the rate of escalation of care or use of ...

Researchers from Children's Hospital of Philadelphia (CHOP) recently found that a device used to measure oxygen levels might be overestimating those levels in children of different races, which could ...

GE HealthCare is recalling 7559 TruSignal arterial oxygen saturation (SpO2) sensors because of problems that may reduce defibrillation energy, expose patients to unintended voltage, or give inaccurate ...

Background and aims: Pulse oximetry (SpO2) is a fundamental aspect of PIC (Paediatric Intensive Care) (Hanning and Alexander-Williams, 1995). Due to widespread use of pulse oximetry, competence and ...

Please provide your email address to receive an email when new articles are posted on . New data published in JAMA indicate that continuous pulse oximetry monitoring is being used often in children ...

Noting the high incidence of childhood pneumonia in many parts of the world, the inclusion of oxygen saturation (SpO2) and respiratory rate measurement in pneumonia screening guidelines, and the ...

Background/aims: Critical congenital cardiovascular malformations (CCVMs) have been defined as lesions likely requiring surgical correction during the first month of life. CCVMs are relatively common, ...

Pulse oximetry, a non-invasive procedure that measures the amount of oxygen in the bloodstream, can be used as a screening tool to detect critical congenital heart disease (CCHD) in infants, and is ...

Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings and forecasts to breaking news and portfolio analysis. Discover high-conviction stock picks and new investing ...

According to a recommendation by a federal advisory panel, before newborns leave the hospital, they should receive a simple, pain-free test to check for signs of congenital heart disease, one of the ...

NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced the results of a study published in Pneumonia in which independent researchers in New Delhi, India, investigated the ...